G Greg Wang
Affiliations: | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
stem cells, cancer, epigeneticsGoogle:
"G Greg Wang"Parents
Sign in to add mentorMark Kamps | grad student | (Neurotree) | |
C. David Allis | post-doc | Rockefeller (PombeTree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Corbin J, Yu X, Jin J, et al. (2024) EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth. Oncogene |
Chen X, Guo Y, Zhao T, et al. (2024) Structural basis for the H2AK119ub1-specific DNMT3A-nucleosome interaction. Nature Communications. 15: 6217 |
Lu J, Guo Y, Yin J, et al. (2024) Structure-guided functional suppression of AML-associated DNMT3A hotspot mutations. Nature Communications. 15: 3111 |
Guo Y, Yu Y, Wang GG. (2023) Polycomb Repressive Complex 2 in Oncology. Cancer Treatment and Research. 190: 273-320 |
Yu X, Li D, Kottur J, et al. (2023) Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer. Journal of Medicinal Chemistry |
Zhao S, Lu J, Pan B, et al. (2023) TNRC18 engages H3K9me3 to mediate silencing of endogenous retrotransposons. Nature |
Dardis GJ, Wang J, Simon JM, et al. (2023) An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer. Iscience. 26: 107115 |
Xu C, Kim A, Corbin JM, et al. (2023) Onco-condensates: formation, multi-component organization, and biological functions. Trends in Cancer |
Hanley RP, Nie DY, Tabor JR, et al. (2023) Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2. Journal of the American Chemical Society |
Chi P, Lewis PW, Lu C, et al. (2023) Charles David Allis (1951-2023). Nature Genetics |